BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

NCT01354431 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

BIOLOGICAL: nivolumab
BIOLOGICAL: nivolumab
BIOLOGICAL: nivolumab

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]